GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » EBITDA Margin %

Universal Vision Biotechnology Co (ROCO:3218) EBITDA Margin % : 33.44% (As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Universal Vision Biotechnology Co's EBITDA for the three months ended in Jun. 2024 was NT$348 Mil. Universal Vision Biotechnology Co's Revenue for the three months ended in Jun. 2024 was NT$1,039 Mil. Therefore, Universal Vision Biotechnology Co's EBITDA margin for the quarter that ended in Jun. 2024 was 33.44%.


Universal Vision Biotechnology Co EBITDA Margin % Historical Data

The historical data trend for Universal Vision Biotechnology Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Vision Biotechnology Co EBITDA Margin % Chart

Universal Vision Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.10 42.72 41.64 42.30 43.62

Universal Vision Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.71 43.85 42.62 44.35 33.44

Competitive Comparison of Universal Vision Biotechnology Co's EBITDA Margin %

For the Medical Devices subindustry, Universal Vision Biotechnology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Vision Biotechnology Co's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Vision Biotechnology Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Universal Vision Biotechnology Co's EBITDA Margin % falls into.



Universal Vision Biotechnology Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Universal Vision Biotechnology Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1780.558/4082.256
=43.62 %

Universal Vision Biotechnology Co's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=347.62/1039.423
=33.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Vision Biotechnology Co  (ROCO:3218) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Universal Vision Biotechnology Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Vision Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115
Universal Vision Biotechnology Co Ltd provides eye treatment and related medical services in Taiwan. It also provides optical devices, glasses, lens and other vision aid products, optometric services, sales and leasing of medical devices, providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co Headlines

No Headlines